EC Number |
Substrates |
Organism |
Products |
Reversibility |
---|
2.4.3.2 | 2 CMP-N-acetyl-beta-neuraminate + 2 methyl beta-D-(3-O-sulfo)Gal-(1->3)-beta-D-GalNAc-(1->3)-alpha-D-Gal |
- |
Rattus norvegicus |
2 CMP + methyl alpha-Neu5Ac-(2->2)-beta-D-(3-O-sulfo)Gal-(1->3)-beta-D-GalNAc-(1->3)-alpha-D-Gal + methyl alpha-Neu5Ac-(2->4)-beta-D-(3-O-sulfo)Gal-(1->3)-beta-D-GalNAc-(1->3)-alpha-D-Gal |
- |
? |
2.4.3.2 | asialo-alpha1 acid glycoprotein |
- |
Sus scrofa |
? |
- |
? |
2.4.3.2 | CMP-N-acetyl-beta-neuraminate + 2-azidoethyl beta-D-Gal-(1->3)-beta-D-GalNAc |
- |
Takifugu rubripes |
CMP + 2-azidoethyl alpha-Neu5Ac-(2->3)-beta-D-Gal-(1->3)-beta-D-GalNAc |
- |
? |
2.4.3.2 | CMP-N-acetyl-beta-neuraminate + 2-azidoethyl beta-D-Gal-(1->3)-beta-D-GalNAc |
- |
Ciona intestinalis |
CMP + 2-azidoethyl alpha-Neu5Ac-(2->3)-beta-D-Gal-(1->3)-beta-D-GalNAc |
- |
? |
2.4.3.2 | CMP-N-acetyl-beta-neuraminate + 3-O-[beta-D-Gal-(1->3)-beta-D-GalNAc]-N-acetyl-L-threonine methyl ester |
- |
Takifugu rubripes |
CMP + 3-O-[alpha-Neu5Ac-(2->3)-beta-D-Gal-(1->3)-beta-D-GalNAc]-N-acetyl-L-threonine methyl ester |
- |
? |
2.4.3.2 | CMP-N-acetyl-beta-neuraminate + 3-O-[beta-D-Gal-(1->3)-beta-D-GalNAc]-N-acetyl-L-threonine methyl ester |
- |
Ciona intestinalis |
CMP + 3-O-[alpha-Neu5Ac-(2->3)-beta-D-Gal-(1->3)-beta-D-GalNAc]-N-acetyl-L-threonine methyl ester |
- |
? |
2.4.3.2 | CMP-N-acetyl-beta-neuraminate + a beta-D-galactosyl-(1->3)-N-acetyl-beta-D-galactosaminyl-R |
- |
Sus scrofa |
CMP + an N-acetyl-alpha-neuraminyl-(2->3)-beta-D-galactosyl-(1->3)-N-acetyl-beta-D-galactosaminyl-R |
- |
? |
2.4.3.2 | CMP-N-acetyl-beta-neuraminate + a beta-D-galactosyl-(1->3)-N-acetyl-beta-D-galactosaminyl-R |
- |
Homo sapiens |
CMP + an N-acetyl-alpha-neuraminyl-(2->3)-beta-D-galactosyl-(1->3)-N-acetyl-beta-D-galactosaminyl-R |
- |
? |
2.4.3.2 | CMP-N-acetyl-beta-neuraminate + agalactofetuin |
- |
Sus scrofa |
? |
- |
? |
2.4.3.2 | CMP-N-acetyl-beta-neuraminate + allyl beta-D-Gal-(1->3)-beta-D-GalNAc |
24.1% of the activity compared to allylbeta-D-Gal-(1->4)-beta-D-GlcNAc, alpha2,3(N) sialyltransferase. 112% of the activity compared to benzyl beta-D-(3-O-Me)Gal-(1->4)-beta-D-GlcNAc-(1->6)-[beta-D-Gal-(1->3)]-alpha-D-GalNAc, alpha2,3(O) sialyltransferase |
Rattus norvegicus |
CMP + allyl alpha-Neu5Ac-(2->3)-beta-D-Gal-(1->3)-beta-D-GalNAc |
- |
? |